DUSA Pharmaceuticals (DUSA)
DUSA Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -0.3371M | 3.307M | 3.507M | 1.111M | -0.6049M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.1632M | 0.1131M | 0.1114M | 0.1062M | 0.1014M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 1.877M | 1.466M | -3.772M | 0.2688M | 2.412M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 2.040M | 1.579M | -3.661M | 0.3749M | 2.514M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -0.4801M | -0.8881M | 0.5235M | 0.6066M | -0.3291M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | 1.223M | 3.998M | 0.3694M | 2.092M | 1.580M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.1828M | -0.9425M | -0.0609M | 0.6154M | -0.0756M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -2.684M | 2.25M | 5.215M | 2.151M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Investing Activities | -0.0001M | 0.7508M | -0.0002M | -0.0003M | -0.0003M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -0.1829M | -2.876M | 2.189M | 5.830M | 2.075M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 0.2363M | 0.5162M | -0.5157M | 0.3892M | 0.1265M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | -0.4635M | -0.5157M | 0.5157M | -0.0428M | -0.191M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | -0.2271M | 0.0006M | 0.00 | 0.3464M | -0.0645M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | 0.8126M | -0.0371M | 2.558M | 8.269M | 3.590M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 24.42M | 8.884M | 23.26M | 23.30M | 20.74M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 25.24M | 23.26M | 23.30M | 20.74M | 12.47M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
